These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15835740)

  • 1. A novel, lipid-free nanodispersion formulation of propofol and its characterization.
    Chen H; Zhang Z; Almarsson O; Marier JF; Berkovitz D; Gardner CR
    Pharm Res; 2005 Mar; 22(3):356-61. PubMed ID: 15835740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured Lipid Carrier of Propofol: a Promising Alternative to Marketed Soybean Oil-Based Nanoemulsion.
    Shevalkar G; Pai R; Vavia P
    AAPS PharmSciTech; 2019 May; 20(5):201. PubMed ID: 31139968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics.
    Ravenelle F; Gori S; Le Garrec D; Lessard D; Luo L; Palusova D; Sneyd JR; Smith D
    Pharm Res; 2008 Feb; 25(2):313-9. PubMed ID: 18030606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats.
    Dutta S; Ebling WF
    J Pharm Pharmacol; 1998 Jan; 50(1):37-42. PubMed ID: 9504432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A propofol microemulsion with low free propofol in the aqueous phase: formulation, physicochemical characterization, stability and pharmacokinetics.
    Cai W; Deng W; Yang H; Chen X; Jin F
    Int J Pharm; 2012 Oct; 436(1-2):536-44. PubMed ID: 22814221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol.
    Li G; Fan Y; Li X; Wang X; Li Y; Liu Y; Li M
    Int J Pharm; 2012 Apr; 425(1-2):53-61. PubMed ID: 22266535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of an alternative triglyceride-free propofol microemulsion.
    Cho J; Cho JC; Lee P; Lee M; Oh E
    Arch Pharm Res; 2010 Sep; 33(9):1375-87. PubMed ID: 20945136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of new propofol aqueous solutions for intravenous anesthesia.
    Trapani A; Laquintana V; Lopedota A; Franco M; Latrofa A; Talani G; Sanna E; Trapani G; Liso G
    Int J Pharm; 2004 Jun; 278(1):91-8. PubMed ID: 15158952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lipid Composition in Propofol Formulations: Decisive Component in Reducing the Free Propofol Content and Improving Pharmacodynamic Profiles.
    Darandale SS; Shevalkar GB; Vavia PR
    AAPS PharmSciTech; 2017 Feb; 18(2):441-450. PubMed ID: 27055535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine model.
    Egan TD; Kern SE; Johnson KB; Pace NL
    Anesth Analg; 2003 Jul; 97(1):72-9, table of contents. PubMed ID: 12818946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation.
    Ravenelle F; Vachon P; Rigby-Jones AE; Sneyd JR; Le Garrec D; Gori S; Lessard D; Smith DC
    Br J Anaesth; 2008 Aug; 101(2):186-93. PubMed ID: 18550641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical properties and stability of two emulsion formulations of propofol.
    Han J; Davis SS; Washington C
    Int J Pharm; 2001 Mar; 215(1-2):207-20. PubMed ID: 11250106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacodynamic effects of a lower-lipid emulsion of propofol: a comparison with the standard propofol emulsion.
    Song D; Hamza M; White PF; Klein K; Recart A; Khodaparast O
    Anesth Analg; 2004 Mar; 98(3):687-91, table of contents. PubMed ID: 14980920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol: the challenges of formulation.
    Baker MT; Naguib M
    Anesthesiology; 2005 Oct; 103(4):860-76. PubMed ID: 16192780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic evaluation and physical/chemical analysis of two formulations of propofol used in target-controlled infusion.
    Simoni RF; Miziara LE; Esteves LO; D'Castro JG; Morales CA; Sandrin CE; Contente TC; Oliveira-Silva D
    Braz J Anesthesiol; 2013 Jan; 63(1):59-65. PubMed ID: 24565090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-free Fluoropolymer-based Propofol Emulsions and Lipid Reversal of Propofol Anesthesia in Rats.
    Parks CL; Tucker W; Amlong CA; Mecozzi S; Pearce RA
    Anesthesiology; 2016 Jun; 124(6):1328-37. PubMed ID: 26938988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emulsion formulation reduces propofol's dose requirements and enhances safety.
    Dutta S; Ebling WF
    Anesthesiology; 1997 Dec; 87(6):1394-405. PubMed ID: 9416725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol.
    Chu Y; Sun T; Xie Z; Sun K; Jiang C
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of microemulsions for improved parenteral delivery of propofol.
    Date AA; Nagarsenker MS
    AAPS PharmSciTech; 2008; 9(1):138-45. PubMed ID: 18446474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation-dependent brain and lung distribution kinetics of propofol in rats.
    Dutta S; Ebling WF
    Anesthesiology; 1998 Sep; 89(3):678-85. PubMed ID: 9743405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.